Wockhardt gains up to 4% after antibiotic Zaynich shows 97% effectiveness in treating drug-resistant infections

Wockhardt Share Price | This new antibiotic combination marks a significant advancement in the battle against multidrug-resistant infections, particularly those that are resistant to current treatments, Wockhardt said in a stock exchange filing.

Leave a Reply

Your email address will not be published. Required fields are marked *